Lamdong Pharmaceutical Joint Stock Company reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was VND 52,420.47 million compared to VND 45,290.87 million a year ago. Net loss was VND 993.69 million compared to VND 8,392.64 million a year ago. Basic loss per share from continuing operations was VND 78 compared to VND 661 a year ago.
For the nine months, revenue was VND 140,675.45 million compared to VND 138,368.95 million a year ago. Net loss was VND 10,240.22 million compared to VND 27,329.69 million a year ago. Basic loss per share from continuing operations was VND 806 compared to VND 2,151 a year ago.